2013
DOI: 10.1016/j.ahj.2013.02.007
|View full text |Cite
|
Sign up to set email alerts
|

Use and long-term outcomes of implantable cardioverter-defibrillators, 1990 to 2009

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
12
1
1

Year Published

2015
2015
2022
2022

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 18 publications
(15 citation statements)
references
References 33 publications
1
12
1
1
Order By: Relevance
“…Other observational studies reported similar mortality rates, although most follow-up periods did not exceed 5 years in these studies. [10][11][12][13][14][15] The incidence of all-cause mortality of ICD recipients was higher in the secondary prevention population; this has not been described before and was only apparent after stratifying for ICD and CRT-D treatments. However, closely reviewing the 3-year mortality rates observed in primary and secondary prevention trials demonstrates a comparable trend.…”
Section: Mortality In Icd and Crt-d Recipientsmentioning
confidence: 79%
See 1 more Smart Citation
“…Other observational studies reported similar mortality rates, although most follow-up periods did not exceed 5 years in these studies. [10][11][12][13][14][15] The incidence of all-cause mortality of ICD recipients was higher in the secondary prevention population; this has not been described before and was only apparent after stratifying for ICD and CRT-D treatments. However, closely reviewing the 3-year mortality rates observed in primary and secondary prevention trials demonstrates a comparable trend.…”
Section: Mortality In Icd and Crt-d Recipientsmentioning
confidence: 79%
“…9 Followup in observational studies does not exceed 5 years, while many patients live more than a decade after device implantation. [10][11][12][13][14][15] Therefore, the aim of the present study was to provide an overview of the long-term clinical outcome of ICD and CRT-D recipients in a large cohort outside the setting of a clinical trial. Clinical outcome includes all-cause mortality, device therapy, device replacements, and device-related complications.…”
Section: Introductionmentioning
confidence: 99%
“…The data sources for the study cohort have been described previously [10]. Briefly, the study used de-identified, linked data prepared by the Data Linkage Branch of the Health Department of WA.…”
Section: Data Sources and Patient Selectionmentioning
confidence: 99%
“…Given the aging critical care population and the escalating global use of implantable cardiac technologies (18,19), the prevalence of these devices in the ICU will likely rise. A practical understanding of these technologies and enhanced comfort in managing emergency complications (including infection and arrhythmia) becomes increasingly more important.…”
Section: Discussionmentioning
confidence: 99%